546 related articles for article (PubMed ID: 14749265)
21. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
22. [Peroxisome proliferator activated receptors (PPAR) and insulin sensitivity: experimental studies].
Haluzík MM; Haluzík M
Cesk Fysiol; 2006; 55(4):163-8. PubMed ID: 17685022
[TBL] [Abstract][Full Text] [Related]
23. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle.
Lapsys NM; Kriketos AD; Lim-Fraser M; Poynten AM; Lowy A; Furler SM; Chisholm DJ; Cooney GJ
J Clin Endocrinol Metab; 2000 Nov; 85(11):4293-7. PubMed ID: 11095470
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
Plutzky J
Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
27. PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval C; Fruchart JC; Staels B
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
[TBL] [Abstract][Full Text] [Related]
28. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
Tamori Y; Masugi J; Nishino N; Kasuga M
Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
[TBL] [Abstract][Full Text] [Related]
29. The mechanisms of action of PPARs.
Berger J; Moller DE
Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
[TBL] [Abstract][Full Text] [Related]
30. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
31. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer.
Gelman L; Fruchart JC; Auwerx J
Cell Mol Life Sci; 1999 Jun; 55(6-7):932-43. PubMed ID: 10412372
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptors: from genes to physiology.
Kliewer SA; Xu HE; Lambert MH; Willson TM
Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
[TBL] [Abstract][Full Text] [Related]
33. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.
Takano H; Hasegawa H; Zou Y; Komuro I
Curr Pharm Des; 2004; 10(22):2779-86. PubMed ID: 15320743
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
Fruchart JC; Duriez P; Staels B
Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
[TBL] [Abstract][Full Text] [Related]
35. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
[TBL] [Abstract][Full Text] [Related]
36. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
37. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Rangwala SM; Lazar MA
Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
[TBL] [Abstract][Full Text] [Related]
39. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.
Loviscach M; Rehman N; Carter L; Mudaliar S; Mohadeen P; Ciaraldi TP; Veerkamp JH; Henry RR
Diabetologia; 2000 Mar; 43(3):304-11. PubMed ID: 10768091
[TBL] [Abstract][Full Text] [Related]
40. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Vázquez M; Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
